You have 9 free searches left this month | for more free features.

arterial inflammation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in San Diego (Cenicriviroc Mesylate (CVC), Placebo)

Withdrawn
  • HIV Infections
  • Cenicriviroc Mesylate (CVC)
  • Placebo
  • (no location specified)
Dec 19, 2022

Inflammation, HIV Infection, Cardiovascular Disease Trial in San Francisco (VB-201, Placebo)

Withdrawn
  • Inflammation
  • +2 more
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Sep 12, 2022

Cardiovascular Diseases, Atherosclerosis, Inflammation Trial in Ottawa (Colchicine Oral Product, Placebo oral capsule)

Recruiting
  • Cardiovascular Diseases
  • +3 more
  • Colchicine Oral Product
  • Placebo oral capsule
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Oct 3, 2022

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

Completed
  • HIV
  • Arterial Imaging
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 4, 2022

Immunomodulatory Effects of PCSK9 Inhibition

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +3 more
  • Contrast-enhanced CCTA
  • 99mTc-tilmanocept SPECT/CT scanning
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 30, 2023

Arterial Stiffness Trial in Vandoeuvre les Nancy cedex (Measure of aortic inflammation)

Completed
  • Arterial Stiffness
  • Measure of aortic inflammation
  • Vandoeuvre les Nancy cedex, France
    CHRU Nancy
Nov 28, 2023

Diabetes, Type 2, Vascular Inflammation Trial in Amsterdam (Atorvastatin 40 Mg Oral Tablet)

Completed
  • Diabetes Mellitus, Type 2
  • Vascular Inflammation
  • Atorvastatin 40 Mg Oral Tablet
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location AMC
Feb 7, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)

Recruiting
  • Atherosclerosis of Artery
  • +3 more
  • Rivaroxaban 2.5mg
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 2, 2023

Ultrasound Markers of Systemic Inflammation

Completed
  • Inflammation Process
  • +4 more
  • Ultrasound measurement
  • Osijek, Croatia
    Slavica Kvolik
Mar 22, 2023

HIV-1-infection Trial in United States (CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg)

Not yet recruiting
  • HIV-1-infection
  • CVC 150 mg
  • +3 more
  • Los Angeles, California
  • +16 more
Nov 22, 2022

Arterial Inflammation Trial in Los Angeles (No drug or device, only a test. The test is called a PET/CT)

Recruiting
  • Arterial Inflammation
  • No drug or device, only a test. The test is called a PET/CT
  • Los Angeles, California
    UCaliforniaLA
Mar 9, 2021

Aortic Infections and Inflammations, Mycotic Aneurysm, Arterial Infections and Inflammations Trial in Vandoeuvre Les Nancy

Not yet recruiting
  • Aortic Infections and Inflammations
  • +3 more
    • Vandoeuvre Les Nancy, Lorraine, France
      Université de Lorraine, CHRU Nancy and APEMAC
    Dec 19, 2022

    Inflammatory Bowel Disease and Atherosclerosis Development

    Recruiting
    • Inflammatory Bowel Diseases
    • +3 more
      • Moscow, Russian Federation
        University Hospital #1
      Mar 12, 2023

      Peripheral Artery Disease (D058729), Oxidative Stress (D018384), Inflammation (D007249) Trial in Salt Lake City (PB125, Placebo,

      Not yet recruiting
      • Peripheral Artery Disease (D058729)
      • +2 more
      • PB125
      • +2 more
      • Salt Lake City, Utah
      • +1 more
      Dec 8, 2022

      Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)

      Withdrawn
      • Atherosclerosis of Artery
      • +4 more
      • Changsha, Hunan, China
      • +1 more
      Jun 9, 2023

      Venous Thromboembolism, covid19, Thrombosis Trial in Ryazan' (standard of care anticoagulation in absence of thrombotic

      Recruiting
      • Venous Thromboembolism
      • +2 more
      • standard of care anticoagulation in absence of thrombotic complications
      • +2 more
      • Ryazan', Russian Federation
        Ryazan State Medical University
      Feb 2, 2022

      HIV Trial in Boston (Teduglutide, Placebo)

      Completed
      • HIV
      • Boston, Massachusetts
        Massachusetts General Hospital
      May 26, 2021

      Peripheral Arterial Disease Trial in San Francisco (Pro-Omega, Omega 3 Fatty Acid)

      Completed
      • Peripheral Arterial Disease
      • Pro-Omega
      • Omega 3 Fatty Acid
      • San Francisco, California
        University of California San Francisco
      Oct 28, 2021

      Oxidative Stress, Endothelial Function, Blood Pressure Trial in Athens (tahini and bread, margarine, cheese and bread)

      Not yet recruiting
      • Oxidative Stress
      • +5 more
      • tahini and bread
      • margarine, cheese and bread
      • Athens, Greece
        Panagiotis Kanellos
      Aug 4, 2022

      The Expression and Significance of MiRNA

      Completed
      • Pulmonary Arterial Hypertension
        • Columbus, Ohio
          The Ohio State University
        Oct 27, 2021

        Acute Coronary Syndrome, Lipoproteinemia, Inflammation Trial in Ljubljana (Pelacarsen (TQJ230), Placebo)

        Withdrawn
        • Acute Coronary Syndrome
        • +3 more
        • Pelacarsen (TQJ230)
        • Placebo
        • Ljubljana, Slovenia
          University Medical Centre Ljubljana-Department of Vascular disea
        Dec 10, 2021

        Shock, Cardiogenic, Extra-Corporeal-Life-Support ( ECLS), Autonomic Nervous System Diseases Trial in Nancy (Biological)

        Recruiting
        • Shock, Cardiogenic
        • +3 more
        • Biological
        • Nancy, France
          CHRU Nancy
        Feb 24, 2022

        Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation Trial in Hamilton (Colchicine 0.5 MG Oral Tablet,

        Recruiting
        • Peripheral Arterial Disease
        • +2 more
        • Colchicine 0.5 MG Oral Tablet
        • Colchicine-Placebo
        • Hamilton, Ontario, Canada
          Hamilton General Hospital
        Sep 14, 2021

        Obesity, Childhood, Obesity, Endothelial Dysfunction Trial in Brussels (Anthropometry, Blood pressure, Peripheral arterial

        Active, not recruiting
        • Obesity, Childhood
        • +4 more
        • Anthropometry
        • +4 more
        • Brussels, Belgium
          University Hospital of Brussels
        May 3, 2021